Related Experiment Video
Updated: Oct 5, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Clinical features of treatment-resistant depression
1Department of Psychiatry, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0253, USA.
Abstract:
As many as 30% to 40% of patients with major depressive disorder are unresponsive to a trial of antidepressant medication. Many patients labeled with treatment-resistant depression actually have pseudoresistance, in that they have been inadequately treated or are misdiagnosed. Others may have unrecognized comorbid psychiatric or general medical conditions that contribute to treatment resistance. Variables such as gender, family history, age at onset, severity, and chronicity have also been evaluated as possible risk factors for treatment-resistant depression. This article reviews the current literature regarding the clinical characteristics of treatment-resistant depression, with particular attention to the relevance of these factors for clinical decision making.
More Related Videos
Related Concept Videos
Treatment Resistent Cancers
Antidepressant Drugs: MAOIs and Other Agents
Psychosis: Goals of Pharmacotherapy
Treatment Resistant Cancers
Depression: Overview
Psychosis and Antipsychotic Drugs: Overview

